Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.41 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.37 |
| ▸ | PKM | P14618 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 6/20 | 0.35 |
| ▸ | LMNA | P02545 | 2/20 | 0.34 |
| ▸ | RAB9A | P51151 | 6/20 | 0.33 |
| ▸ | NPC1 | O15118 | 4/20 | 0.33 |
| ▸ | MEN1 | O00255 | 2/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL111353 | 0.95 | ALDH1A1 (0.47) | ALDH1A1ALOX15PKMSMN1; SMN2LMNA | |
| Formaldehyde SCHEMBL28262224 | 0.90 | ALDH1A1 (0.47) | ALDH1A1ALOX15PKMSMN1; SMN2LMNA | |
| Pyrrole SCHEMBL28288914 | 0.87 | ALDH1A1 (0.42) | ALDH1A1ALOX15PKMSMN1; SMN2LMNA | |
| SCHEMBL4992463 | 0.86 | ALDH1A1 (0.39) | ALDH1A1ALOX15PKMSMN1; SMN2LMNA | |
| SCHEMBL4450400 | 0.79 | ALDH1A1 (0.30) | ALDH1A1 | |
| SCHEMBL17267390 | 0.78 | ALDH1A1 (0.41) | ALDH1A1ALOX15PKMSMN1; SMN2LMNA | |
| SCHEMBL9176557 | 0.77 | ALDH1A1 (0.42) | ALDH1A1ALOX15PKMSMN1; SMN2RAB9A | |
| SCHEMBL28290439 | 0.75 | ALDH1A1 (0.36) | ALDH1A1SMN1; SMN2LMNARAB9ANPC1 | |
| SCHEMBL9755511 | 0.75 | ALDH1A1 (0.41) | ALDH1A1ALOX15PKMSMN1; SMN2RAB9A | |
| SCHEMBL10948510 | 0.75 | ALDH1A1 (0.49) | ALDH1A1ALOX15SMN1; SMN2LMNARAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1067118-B1 | Cyclopentylalkyl-nitriles and the use of odoriferous cyclopentylalkyl derivatives as fragrances | GIVAUDAN SA (CH) | 2004-03-31 | — | — | EP | disclosed |
| US-6441052-B1 | ALKANOL, ALDEHYDE, AND KETONE CYCLOPENTA DERIVATIVES; FRAGRANCES | GIVAUDAN SA (CH) | 2002-08-27 | — | — | US | disclosed |
| US-20020086901-A1 | CYCLOPENTYLALKYL-NITRILES | GIVAUDAN SA, A SWITZERLAND CORPORATION | 2002-07-04 | — | — | US | disclosed |
| US-6410000-B1 | PERFUME | GIVAUDAN SA (CH) | 2002-06-25 | — | — | US | disclosed |
| US-6399811-B1 | ORGANOLEPTIC | GIVAUDAN SA (CH) | 2002-06-04 | — | — | US | disclosed |
| EP-1067118-A1 | Cyclopentylalkyl-nitriles and the use of odoriferous cyclopentylalkyl derivatives as fragrances | Givaudan SA (CH) | 2001-01-10 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020086901-A1 | CYCLOPENTYLALKYL-NITRILES | CCRL2, CBR1, CNR1 | ALDH1A1 479/4885ALOX15 1600/4885PKM 4151/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.